Can Fite Biofarma Ltd.
13F holders, Q3 2025 (September 30)16holders
2new positions
2sold out
$0.62avg. 13F price*
At the end of Q3 2025, 16 institutions reported holding Can Fite Biofarma Ltd. in their 13F filings, unchanged from Q2 2025. 2 opened new positions and 2 sold out. The largest holders were Sabby Management, LLC ($871K), Rhumbline Advisers ($36K) and BNP Paribas Financial Markets ($10K).
- Company
- Can Fite Biofarma Ltd.
- CUSIP
- 13471N300
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $9K |
| Exits | 2 | $195 |
All 13F filers, Q2 2025 → Q3 2025: 644,412 shares bought and 10,815 shares sold, net +633,597 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Sabby Management, LLC | 4.55% | Add +80.3% | 1,406,050 | $871K |
| Rhumbline Advisers | 0.00% | Add +0.6% | 57,932 | $36K |
| BNP Paribas Financial Markets | 0.00% | Reduce -5.7% | 16,585 | $10K |
| Bogart Wealth, LLC | 0.00% | New | 15,045 | $9K |
| Morgan Stanley | 0.00% | Add +26.7% | 12,555 | $8K |
| Captrust Financial Advisors | 0.00% | No change | 11,375 | $7K |
| Two Sigma Securities, LLC | 0.00% | Reduce -33.8% | 10,642 | $7K |
| Fifth Third Bancorp | 0.00% | No change | 3,000 | $2K |
| Wells Fargo & Company | 0.00% | No change | 2,700 | $2K |
| UBS Group AG | 0.00% | Reduce -76.3% | 1,308 | $810 |
| Costello Asset Management, INC | 0.00% | No change | 1,000 | $619 |
| Activest Wealth Management | 0.00% | No change | 200 | $124 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 68 | $42 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 20 | $12 |
| SBI Securities Co., Ltd. | 0.00% | No change | 1 | $1 |
| Avion Wealth | 0.00% | No change | 100 | $0 |
"% of holder's portfolio" is CAN FITE BIOFARMA LTD's weight in each manager's 13F, not the share of Can Fite Biofarma Ltd. the manager owns.